Staphylococcus aureus fibronectin binding protein a mediates biofilm development and infection

Casey M. Gries, Trevor Biddle, Jeffrey L. Bose, Tammy Kielian, David D. Lo

Research output: Contribution to journalArticlepeer-review

24 Scopus citations


Implanted medical device-associated infections pose significant health risks, as they are often the result of bacterial biofilm formation. Staphylococcus aureus is a leading cause of biofilm-associated infections which persist due to mechanisms of device surface adhesion, biofilm accumulation, and reprogramming of host innate immune responses. We found that the S. aureus fibronectin binding protein A (FnBPA) is required for normal biofilm development in mammalian serum and that the SaeRS two-component system is required for functional FnBPA activity in serum. Furthermore, serum-developed biofilms deficient in FnBPA were more susceptible to macrophage invasion, and in a model of biofilm-associated implant infection, we found that FnBPA is crucial for the establishment of infection. Together, these findings show that S. aureus FnBPA plays an important role in physical biofilm development and represents a potential therapeutic target for the prevention and treatment of device-associated infections.

Original languageEnglish (US)
Article numbere00859-19
JournalInfection and immunity
Issue number5
StatePublished - Apr 1 2020


  • Biofilm
  • Fibronectin binding protein
  • Infection
  • S. aureus

ASJC Scopus subject areas

  • Parasitology
  • Microbiology
  • Immunology
  • Infectious Diseases


Dive into the research topics of 'Staphylococcus aureus fibronectin binding protein a mediates biofilm development and infection'. Together they form a unique fingerprint.

Cite this